Form 4 for VIVS VivoSim Labs, INC.
Accepted 2023-11-17 00:00:00 ET · period of report 2023-11-15 · accession 0000950170-23-064944 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-17 | 2023-11-17 | VIVS | Gobel David | Dir | A - Grant | $0.00 | +19.6K | 19.6K | New | $0 | |
| 2023-11-17 | 2023-11-15 | VIVS | Gobel David | Dir | S - Sale | $1.62 | -19.6K | 0 | -100% | -$31.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-17 | A | A | 19,607 | $0.00 | 19,607 | D | — | — | (F2) The reported securities are represented by restricted stock units, which shall vest on the earlier of November 17, 2024 or the date of the next annual meeting of stockholders held by the Issuer, subject to acceleration in the event of a change of control. |
| 2 | Common | Common Stock | 2023-11-15 | S | D | 19,607 | $1.62 | 0 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.615 to $1.64, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |